MedPath

Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP

Phase 3
Completed
Conditions
Pneumonia
Interventions
Registration Number
NCT01529476
Lead Sponsor
TaiGen Biotechnology Co., Ltd.
Brief Summary

1. This study will test the safety and efficacy of TG-873870 (Nemonoxacin) compared with Levofloxacin in adult patients with Community-Aquired Pneumonia (CAP)

2. To investigate the population pharmacokinetics (PPK) of nemonoxacin in adult patients with CAP after continuous oral administration and determine the pharmacokinetic (PK)/pharmacodynamic (PD).

Detailed Description

Community-acquired Pneumonia (CAP) remains a leading cause of death in both developing and developed countries. In the choice of antibacterial agents used to treat CAP, fluoroquinolones have received considerable attention because of their wide spectrum of bactericidal activity. TG-873870 (Nemonoxacin), a non-fluorinated quinolone (NFQ), is a selective bacterial topoisomerase inhibitor. This study will test the safety and efficacy of TG-873870 (Nemonoxacin) compared with Levofloxacin in adult patients with Community-Aquired Pneumonia (CAP).

Besides,the population pharmacokinetics (PPK) of nemonoxacin in adult patients with CAP after continuous oral administration and determine the pharmacokinetic (PK)/pharmacodynamic (PD).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
540
Inclusion Criteria
  1. Ages between 18 and 70;
  2. Weighs between 40 ~ 100 kg, and BMI ≥ 18 kg/m2;
  3. Must have a clinical diagnosis of CAP
  4. Chest X-ray shows new or persist/progressive infiltrates
  5. If female, non-lactating and at no risk or pregnancy (post-menopausal or must use adequate birth control)
  6. The patient is able to take the drug orally.
Exclusion Criteria
  1. Patients with CAP that, in the investigator's judgment, is severe enough to require hospitalization for intravenous antibiotic therapy and/or supplemental oxygen therapy with ICU support
  2. Known or suspected severe bronchiectasis, cystic fibrosis, active pulmonary tuberculosis or infection with other mycobacteria or fungi, known bronchial obstruction, a history of post-obstructive pneumonia, other confounding respiratory diseases, such as lung cancer, malignancy metastatic to the lungs, lung abscess, empyema, suspected aspiration pneumonia due to vomiting, or non-bacterial respiratory infection (chronic obstructive pulmonary disease [COPD] is not exclusionary)
  3. Clinically significant conduction or other abnormality on 12-lead ECG, or QTc interval
  4. Potassium is < 3.5 mmol/L
  5. Any known disease that seriously affect the immune system
  6. Active hepatitis or decompensated cirrhosis;
  7. Have used quinolones or fluoroquinolones within 14 days before enrollment
  8. Patients who are being or will be on a long-term medication of steroids

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nemonoxacin 500 mgNemonoxacin-
Levofloxacin 500 mgLevofloxacin-
Primary Outcome Measures
NameTimeMethod
Per subject clinical cure rate21days

The clinical cure rate will be evaluated according to signs and symptoms and changes in the chest X-ray.

Secondary Outcome Measures
NameTimeMethod
Safety Evaluation24days

Clinical adverse events and abnormal laboratory or other special test findings during this study should be observed and recorded carefully.

Per subject microbiological cure rate14 days

The microbiological cure rate will be evaluated according to the microbiological identification results of the central laboratory

Per subject overall cure rate14 days

Evaluate the overall efficacy after a comprehensive consideration of the clinical results and the bacteriological results.

Trial Locations

Locations (57)

Beijing Union Medical College Hospital

🇨🇳

Beijing, China

China Medical University Hospital

🇨🇳

Taichung, Taiwan

Anzhen Hospital,Beijing Capital Medical University

🇨🇳

Anzhen, China

Sun Yet-sen Memorial Hospital

🇨🇳

Guangzhou, China

Huadong Hospital of Fudan University

🇨🇳

Shanghai, China

Wuhan General Hospital of Guangzhou Millitary Command

🇨🇳

Wuhan, China

People's Hospital of Gansu Province

🇨🇳

Gansu, China

GuangZhou Red Cross Hospital

🇨🇳

GuangZhou, China

Affilated Hospital of Guilin Medical college

🇨🇳

Guilin, China

Hainan Provincial People's Hospital

🇨🇳

Hainan, China

Hospital Affiliated to Hainan Medical College

🇨🇳

Hainan, China

Hubei General Hospital

🇨🇳

Hubei, China

Taihe Hospital

🇨🇳

Hubei, China

Hunan Provincial People's Hospital

🇨🇳

Hunan, China

Third Xiangya Hospital,Central South University

🇨🇳

Hunan, China

People's Hospital of Jiangxi Province

🇨🇳

Jiangxi, China

Jinan Central Hospital

🇨🇳

Jinan, China

Lanzhou university second hospital

🇨🇳

Lanzhou, China

Shengjing Hospital of China Medical University

🇨🇳

Liaoning, China

Second Affiliated Hospital of Nanchang University

🇨🇳

Nanchang, China

Peking University People's Hospital

🇨🇳

Peking, China

Putuo Central Hospital

🇨🇳

Shanghai, China

Shanghai Changzheng Hospital

🇨🇳

Shanghai, China

Shanghai East Hospital in Pudong New Area

🇨🇳

Shanghai, China

The First Hospital of Shanxi Medical College

🇨🇳

Shanxi, China

PLA General Hospital of Shenyang Military Region

🇨🇳

Shenyang, China

ShenZhen People's Hospital

🇨🇳

ShenZhen, China

Institute of Antibiotics,Huashan Hospital ,Fudan University

🇨🇳

Shianghai, China

Department of Resoiratory Medicine,West China Hospital of Sichuan University

🇨🇳

Sichuan, China

Shanghai Sixth People's Hospital

🇨🇳

Shanghai, China

Shuang Ho Hospital

🇨🇳

Taipei, China

The Second Hospital of Wenzhou Medical College

🇨🇳

Wenzhou, China

First Affiliated Hospital,Zhejiang University School of Medicine

🇨🇳

Zhejiang, China

Chia-Yi Christian Hospital

🇨🇳

Chia-Yi, Taiwan

Yuan's General Hospital

🇨🇳

Kaohsiung, Taiwan

Veterans General Hospital-Taipei

🇨🇳

Taipei, Taiwan

ChiMei Medical Hospital-Liuying branch

🇨🇳

Liuying, Taiwan

Cheng Ching General Hospital

🇨🇳

Taichung, Taiwan

Veterans General Hospital-TaiChung

🇨🇳

TaiChung, Taiwan

General Hospital of PLA Second Artillery

🇨🇳

Beijing, China

West China Hospital of Sichuan University,Center for Infection Disease

🇨🇳

Chengdu, China

PLA Third Militrary Medical University,Second Affiliated Hospital

🇨🇳

Chongqing, China

Beijing Chaoyang Hospital

🇨🇳

Chaoyang, China

PLA Third Militrary Medical University,Third Affiliated Hospital

🇨🇳

Chongqing, China

The First Affiliated Hospital,Chongqing Medical University

🇨🇳

Chongqing, China

The First Hospital of Fujian Medical University

🇨🇳

Fuzhou, China

The First Affiliated Hospital,Xinjiang Medical University

🇨🇳

Xinjiang, China

Chung Shan Medical University Hospital

🇨🇳

Taichung, Taiwan

Kaohsiung hang Gung Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Cheng Hsin General Hospital

🇨🇳

Taipei, Taiwan

E-Da Hospital

🇨🇳

Kaohsiung, Taiwan

Far-East Memorial Hospital

🇨🇳

Taipei, Taiwan

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

Tri-Service General Hospital

🇨🇳

Taipei, Taiwan

Nanjing Genrak Hospital of Nanjing Millitary Command

🇨🇳

Nanjing, China

Peking University First Hospital

🇨🇳

Peking, China

© Copyright 2025. All Rights Reserved by MedPath